The Genentech ELN story
Spending less time on paperwork is a goal for all companies and the pharmaceutical industry is no different. In this Pharma IQ recording, John Trigg, Director, phaseFour Informatics caught up with Martin Vanderlaan, Director of Analytical Operations at Genentech, to discuss Genentech's recent ELN rollout in bioprocess development, a relatively new environment for ELNs. What Does The Future Hold For Electronic Lab Notebooks In 2012? Download the free 2012 ELN Globa...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.